HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:HIMS - US4330001060 - Common Stock
37.36 USD
-0.52 (-1.37%)
Overall HIMS gets a fundamental rating of 5 out of 10. We evaluated HIMS against 100 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of HIMS get a neutral evaluation. Nothing too spectacular is happening here. HIMS shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
In the past year HIMS was profitable.
HIMS had a positive operating cash flow in the past year.
In the past 5 years HIMS reported 4 times negative net income.
In multiple years HIMS reported negative operating cash flow during the last 5 years.
1.2 Ratios
HIMS's Return On Assets of 5.99% is amongst the best of the industry. HIMS outperforms 83.00% of its industry peers.
With an excellent Return On Equity value of 23.03%, HIMS belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 5.84%, HIMS is in the better half of the industry, outperforming 61.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROIC | 5.84% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 6.05%, HIMS belongs to the top of the industry, outperforming 81.00% of the companies in the same industry.
The Operating Margin of HIMS (5.96%) is better than 64.00% of its industry peers.
HIMS's Gross Margin of 75.01% is amongst the best of the industry. HIMS outperforms 90.00% of its industry peers.
HIMS's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HIMS is destroying value.
The number of shares outstanding for HIMS has been increased compared to 1 year ago.
Compared to 5 years ago, HIMS has more shares outstanding
HIMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 4.44 indicates that HIMS is not in any danger for bankruptcy at the moment.
HIMS has a Altman-Z score of 4.44. This is amongst the best in the industry. HIMS outperforms 81.00% of its industry peers.
The Debt to FCF ratio of HIMS is 8.13, which is on the high side as it means it would take HIMS, 8.13 years of fcf income to pay off all of its debts.
HIMS has a Debt to FCF ratio (8.13) which is in line with its industry peers.
A Debt/Equity ratio of 1.67 is on the high side and indicates that HIMS has dependencies on debt financing.
HIMS has a Debt to Equity ratio of 1.67. This is in the lower half of the industry: HIMS underperforms 70.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Altman-Z | 4.44 |
ROIC/WACC0.66
WACC8.82%
2.3 Liquidity
A Current Ratio of 1.88 indicates that HIMS should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.88, HIMS is doing good in the industry, outperforming 76.00% of the companies in the same industry.
A Quick Ratio of 1.64 indicates that HIMS should not have too much problems paying its short term obligations.
HIMS has a Quick ratio of 1.64. This is in the better half of the industry: HIMS outperforms 66.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 22.73% over the past year.
Measured over the past years, HIMS shows a very strong growth in Earnings Per Share. The EPS has been growing by 60.35% on average per year.
Looking at the last year, HIMS shows a very strong growth in Revenue. The Revenue has grown by 78.02%.
The Revenue has been growing by 75.77% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
3.2 Future
The Earnings Per Share is expected to grow by 41.75% on average over the next years. This is a very strong growth
HIMS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.08% yearly.
EPS Next Y-9.33%
EPS Next 2Y10.49%
EPS Next 3Y16.08%
EPS Next 5Y41.75%
Revenue Next Year60.2%
Revenue Next 2Y37.95%
Revenue Next 3Y31.52%
Revenue Next 5Y21.08%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
HIMS is valuated quite expensively with a Price/Earnings ratio of 69.19.
Compared to the rest of the industry, the Price/Earnings ratio of HIMS is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 26.59, HIMS is valued quite expensively.
With a Price/Forward Earnings ratio of 56.67, HIMS can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HIMS is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.80, HIMS is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 69.19 | ||
| Fwd PE | 56.67 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, HIMS is valued a bit more expensive than 60.00% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as HIMS.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 71.18 | ||
| EV/EBITDA | 49.81 |
4.3 Compensation for Growth
HIMS has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as HIMS's earnings are expected to grow with 16.08% in the coming years.
PEG (NY)N/A
PEG (5Y)1.15
EPS Next 2Y10.49%
EPS Next 3Y16.08%
5. Dividend
5.1 Amount
No dividends for HIMS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:HIMS (12/11/2025, 2:58:08 PM)
37.36
-0.52 (-1.37%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners94.02%
Inst Owner Change15.85%
Ins Owners5.88%
Ins Owner Change-2.93%
Market Cap8.51B
Revenue(TTM)2.21B
Net Income(TTM)133.79M
Analysts67.62
Price Target47.53 (27.22%)
Short Float %32.97%
Short Ratio2.5
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.62%
Min EPS beat(2)-43.53%
Max EPS beat(2)10.29%
EPS beat(4)3
Avg EPS beat(4)8.39%
Min EPS beat(4)-43.53%
Max EPS beat(4)62.17%
EPS beat(8)7
Avg EPS beat(8)149.86%
EPS beat(12)10
Avg EPS beat(12)106.48%
EPS beat(16)12
Avg EPS beat(16)73.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-3.17%
Max Revenue beat(2)1.2%
Revenue beat(4)3
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.26%
Revenue beat(12)9
Avg Revenue beat(12)1.39%
Revenue beat(16)13
Avg Revenue beat(16)3.12%
PT rev (1m)-4.55%
PT rev (3m)-7.49%
EPS NQ rev (1m)-32.49%
EPS NQ rev (3m)-66.29%
EPS NY rev (1m)-18.96%
EPS NY rev (3m)-18.37%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)-1.91%
Revenue NY rev (1m)0.29%
Revenue NY rev (3m)0.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 69.19 | ||
| Fwd PE | 56.67 | ||
| P/S | 3.85 | ||
| P/FCF | 71.18 | ||
| P/OCF | 26.16 | ||
| P/B | 14.64 | ||
| P/tB | 67.07 | ||
| EV/EBITDA | 49.81 |
EPS(TTM)0.54
EY1.45%
EPS(NY)0.66
Fwd EY1.76%
FCF(TTM)0.52
FCFY1.4%
OCF(TTM)1.43
OCFY3.82%
SpS9.71
BVpS2.55
TBVpS0.56
PEG (NY)N/A
PEG (5Y)1.15
Graham Number5.57
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROCE | 7.39% | ||
| ROIC | 5.84% | ||
| ROICexc | 9.03% | ||
| ROICexgc | 14.91% | ||
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% | ||
| FCFM | 5.4% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score3
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Debt/EBITDA | 5.57 | ||
| Cap/Depr | 484.08% | ||
| Cap/Sales | 9.3% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 186.53% | ||
| Profit Quality | 89.31% | ||
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 | ||
| Altman-Z | 4.44 |
F-Score3
WACC8.82%
ROIC/WACC0.66
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
EPS Next Y-9.33%
EPS Next 2Y10.49%
EPS Next 3Y16.08%
EPS Next 5Y41.75%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
Revenue Next Year60.2%
Revenue Next 2Y37.95%
Revenue Next 3Y31.52%
Revenue Next 5Y21.08%
EBIT growth 1Y190.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year351.13%
EBIT Next 3Y90.71%
EBIT Next 5Y58.35%
FCF growth 1Y344.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y625.93%
OCF growth 3YN/A
OCF growth 5YN/A
HIMS & HERS HEALTH INC / HIMS FAQ
What is the ChartMill fundamental rating of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a fundamental rating of 5 / 10 to HIMS.
What is the valuation status for HIMS stock?
ChartMill assigns a valuation rating of 2 / 10 to HIMS & HERS HEALTH INC (HIMS). This can be considered as Overvalued.
What is the profitability of HIMS stock?
HIMS & HERS HEALTH INC (HIMS) has a profitability rating of 6 / 10.
What is the earnings growth outlook for HIMS & HERS HEALTH INC?
The Earnings per Share (EPS) of HIMS & HERS HEALTH INC (HIMS) is expected to decline by -9.33% in the next year.